The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Guinan Mark since 2011.
This trader's CIK number is 1505998.
At the time of last reporting, Guinan Mark was the Executive Vice President & CFO of Quest Diagnostics Inc. (stock ticker symbol DGX).
Also see all insider trading activities at Quest Diagnostics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | HRC | 0 | $0 | 0 | $0 | 10,127 | $0 |
| 2011 | HRC | 0 | $0 | 0 | $0 | 10,274 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | DGX | 0 | $0 | 154,352 | $18,404,923 | 154,352 | $10,604,248 |
| 2019 | DGX | 0 | $0 | 73,005 | $7,300,500 | 73,005 | $3,808,305 |
| 2018 | DGX | 0 | $0 | 61,533 | $6,508,899 | 61,533 | $3,591,373 |
| 2015 | DGX | 0 | $0 | 280 | $20,086 | 0 | $0 |
| 2014 | DGX | 4,000 | $222,024 | 0 | $0 | 0 | $0 |
1. Hill-rom Holdings, Inc. (HRC)
2. Quest Diagnostics Inc (DGX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-12-14 | HRC | Option Ex | 10,127 | .00 | 0 |
| 2011-12-14 | HRC | Option Ex | 10,274 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-24 | DGX | Option Ex | 81,756 | 66.51 | 5,437,591 |
| 2020-12-24 | DGX | Sale | 81,756 | 120.62 | 9,861,245 |
| 2020-06-08 | DGX | Option Ex | 72,596 | 71.17 | 5,166,657 |
| 2020-06-08 | DGX | Sale | 72,596 | 117.69 | 8,543,678 |
| 2019-06-13 | DGX | Option Ex | 73,005 | 52.16 | 3,808,305 |
| 2019-06-13 | DGX | Sale | 73,005 | 100.00 | 7,300,500 |
| 2018-05-25 | DGX | Option Ex | 61,533 | 58.37 | 3,591,373 |
| 2018-05-25 | DGX | Sale | 61,533 | 105.78 | 6,508,899 |
| 2015-02-17 | DGX | Sale | 280 | 71.74 | 20,086 |
| 2014-05-05 | DGX | Buy | 4,000 | 55.51 | 222,024 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Guinan Mark (Executive Vice President & CFO of Quest Diagnostics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.